Q3 2025 · 13F-HR
FCPM III SERVICES B.V.holdings as filed
Filed 2025-11-14 · accession 0001193125-25-281853
$500.4M
Reported value
9
Positions
2025-09-30
Period end
The Brief · FCPM III SERVICES B.V. · Q3 2025
AI · grounded in 13F
FCPM III SERVICES B.V. established a new position in NAMS valued at $262M. The fund also added new holdings in DYN for $69.1M and ENGENE HOLDINGS INC for $65.8M. Other new positions include CATBUSD at $29.9M, BCYC at $26.7M, and VOR at $18.5M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $262.0M | 52.4% | 9,212,384 | Common | SHARED |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $69.1M | 13.8% | 5,462,846 | Common | SHARED |
| 29286M105 | — | ENGENE HOLDINGS INC | $65.8M | 13.1% | 9,632,561 | Common | SHARED |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $29.9M | 5.98% | 4,107,537 | Common | SHARED |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $26.7M | 5.34% | 3,452,330 | Common | SHARED |
| 929033207 | VOR | VOR BIOPHARMA INC | $18.5M | 3.70% | 379,640 | Common | SHARED |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $17.4M | 3.48% | 4,158,368 | Common | SHARED |
| 75382E208 | RAPT | RAPT THERAPEUTICS INC | $8.9M | 1.77% | 344,237 | Common | SHARED |
| 29286M113 | — | ENGENE HOLDINGS INC | $2.1M | 0.41% | 2,878,148 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.